Nurix Therapeutics to Participate in RBC Capital Markets Global Healthcare Conference
SAN FRANCISCO, May 07, 2024 (GLOBE NEWSWIRE) — Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company developing targeted protein […]
Harvard Bioscience Announces First Quarter 2024 Financial Results
HOLLISTON, Mass., May 07, 2024 (GLOBE NEWSWIRE) — Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for […]
Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update
On-track to report topline Phase 3 data from KOASTAL-1 study with navacaprant in MDD; guidance narrowed to fourth quarter of […]
Ashland signs definitive agreement to sell nutraceuticals business to Turnspire Capital Partners
WILMINGTON, Del., May 07, 2024 (GLOBE NEWSWIRE) — Ashland Inc. (NYSE: ASH) announced today that it has signed a definitive […]
Asensus Surgical, Inc. Schedules First Quarter Financial and Operating Results Conference Call for May 14, 2024
RESEARCH TRIANGLE PARK, N.C., May 07, 2024 (GLOBE NEWSWIRE) — Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company […]
Reliance, Inc. Announces Upcoming Conference Participation
SCOTTSDALE, Ariz., May 07, 2024 (GLOBE NEWSWIRE) — Reliance, Inc. (NYSE: RS) announced today that its management team will participate […]
SOPHiA GENETICS Reports First Quarter 2024 Results
BOSTON and ROLLE, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) — SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader […]
TSX News -
Descartes’ Annual Ecommerce Study Shows Online Buying Grows but 67% of Consumers Face Delivery Problems
ATLANTA and LONDON, May 07, 2024 (GLOBE NEWSWIRE) — Descartes Systems Group (Nasdaq: DSGX) (TSX:DSG), the global leader in uniting […]
TopBuild Reports First Quarter Results, Raises 2024 Outlook and Announces $1B Share Repurchase Authorization
First quarter sales grow 1.1% to $1.3 billion Gross margin expands 100 basis points to 30.3% Adjusted EBITDA margin expands […]
Robust Mix Sustained a Strong Start to the Year
Robust Mix Sustained a Strong Start to the Year Net revenues of Euro 1,585 million, up 10.9% versus prior year, […]
